Phase 3 Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to sign a consent form agreeing to take part in the study.
- You are between 12 and 80 years old (male or female).
- You weigh at least 30 kg (about 66 pounds).
- You have been diagnosed with Myasthenia Gravis (MG) with symptoms that match the disease.
- Your MG has been classified as "Type I" by your doctor, using a specific medical grading system called the MGFA classification (confirm with trial site).
- You are currently on a steady, unchanged treatment plan for your MG.
Who may not be able to join:
- You have another autoimmune disease that requires you to take steroid medications (such as prednisone).
- Your recent blood or lab test results show significant abnormalities (confirm with trial site).
- You have used additional immune-suppressing medications — beyond your current stable MG treatment — in the past month.
- You currently have an infection (either short-term or long-term) that needs treatment.
- You have active hepatitis or a history of serious liver disease.
- You have tested positive for HIV.
- You have tested positive for syphilis.
- You have poorly controlled diabetes, based on specific blood sugar test results (confirm with trial site).
- You have a thymus gland tumor (thymoma) that falls into certain stages of severity (confirm with trial site).
- You have another uncontrolled long-term illness, mental health condition, or neurological condition (other than MG) that could affect the study results.
- You have another condition — not MG — that causes drooping eyelids, muscle weakness, or double vision (such as a thyroid eye disease or muscular dystrophy).
- You have a known allergy to medicines or products made from human biological material.
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the MGII (PRO) ocular score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.